{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:36:09Z","timestamp":1770899769230,"version":"3.50.1"},"reference-count":35,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Recovery and Resilience Plan of the Republic of Bulgaria","award":["BG-RRP-2.004-0003-C01"],"award-info":[{"award-number":["BG-RRP-2.004-0003-C01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Image-guided adaptive brachytherapy is a standard modality in the treatment of locally advanced cervical cancer. However, the availability of isotope-based brachytherapy is limited in countries with lower resources. The objective of this study is to report the first institutional dosimetric and clinical data on intracavitary electronic brachytherapy. Methods: A total of 25 patients with histologically proven cervical cancer stage IB-IVA were treated with concurrent chemoradiotherapy and electronic brachytherapy. The patients were followed up for a median of 12 months (range 6\u201324). Toxicity was evaluated by the radiation oncologist and gynecologist on each visit and scored by Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Results: All patients completed the treatment successfully with a median overall treatment time (OTT) of 52 days (range 39\u201389). The desired target coverage was achieved in all patients, and the dose limits for the organs at risk were achieved in 88% of the patients. No Grade 3 toxicities occurred. A total of 84% of the patients achieved local control in the cervix, and a complete response was noted in 72% of the patients. Conclusions: Electronic brachytherapy provides the option to deliver a high dose of radiation to the uterine cervix without leading to severe toxicity. Further improvements to the treatment protocol could provide better locoregional and systemic control of the disease. Studies with larger cohorts and longer follow-up are necessary.<\/jats:p>","DOI":"10.3390\/cancers17142286","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:38:27Z","timestamp":1752140307000},"page":"2286","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preliminary Experience with Electronic Brachytherapy in the Treatment of Locally Advanced Cervical Carcinoma"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7422-1709","authenticated-orcid":false,"given":"Desislava","family":"Hitova-Topkarova","sequence":"first","affiliation":[{"name":"Department of Radiotherapy, UMHAT \u201cDr. Georgi Stranski\u201d, 8A Georgi Kochev Blvd., 5809 Pleven, Bulgaria"},{"name":"Scientific and Innovative Program Med for Health, Medical University Pleven, 1, Saint Kliment Ohridski Street, 5800 Pleven, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9405-641X","authenticated-orcid":false,"given":"Virginia","family":"Payakova","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, UMHAT \u201cDr. Georgi Stranski\u201d, 8A Georgi Kochev Blvd., 5809 Pleven, Bulgaria"},{"name":"Scientific and Innovative Program Med for Health, Medical University Pleven, 1, Saint Kliment Ohridski Street, 5800 Pleven, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7719-382X","authenticated-orcid":false,"given":"Angel","family":"Yordanov","sequence":"additional","affiliation":[{"name":"Scientific and Innovative Program Med for Health, Medical University Pleven, 1, Saint Kliment Ohridski Street, 5800 Pleven, Bulgaria"},{"name":"Department of Gynecologic Oncology, UMHAT \u201cDr. Georgi Stranski\u201d, 8A Georgi Kochev Blvd., 5809 Pleven, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8357-7029","authenticated-orcid":false,"given":"Desislava","family":"Kostova-Lefterova","sequence":"additional","affiliation":[{"name":"Scientific and Innovative Program Med for Health, Medical University Pleven, 1, Saint Kliment Ohridski Street, 5800 Pleven, Bulgaria"},{"name":"National Cardiology Hospital, 65 Konyovitsa Street, 1309 Sofia, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirela","family":"Ivanova","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, UMHAT \u201cDr. Georgi Stranski\u201d, 8A Georgi Kochev Blvd., 5809 Pleven, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilko","family":"Iliev","sequence":"additional","affiliation":[{"name":"Scientific and Innovative Program Med for Health, Medical University Pleven, 1, Saint Kliment Ohridski Street, 5800 Pleven, Bulgaria"},{"name":"Department of Gynecologic Oncology, UMHAT \u201cDr. Georgi Stranski\u201d, 8A Georgi Kochev Blvd., 5809 Pleven, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marin","family":"Valkov","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, UMHAT \u201cDr. Georgi Stranski\u201d, 8A Georgi Kochev Blvd., 5809 Pleven, Bulgaria"},{"name":"Scientific and Innovative Program Med for Health, Medical University Pleven, 1, Saint Kliment Ohridski Street, 5800 Pleven, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolay","family":"Mutkurov","sequence":"additional","affiliation":[{"name":"Complex Oncology Centre, 86 Demokratsia Blvd., 8000 Burgas, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-3095","authenticated-orcid":false,"given":"Stoyan","family":"Kostov","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Medical University Varna \u201cProf. Dr. Paraskev Stoyanov\u201d, 9002 Varna, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elitsa","family":"Encheva","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, UMHAT \u201cSaint Marina\u201d, 1 Hristo Smirnenski Blvd., 9010 Varna, Bulgaria"},{"name":"Department of Imaging Diagnostics, Interventional Radiology and Radiotherapy, Medical University of Varna, 9000 Varna, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"ref_1","unstructured":"Ferlay, J., Ervik, M., Lam, F., Laversanne, M., Colombet, M., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2024). Global Cancer Observatory: Cancer Today, International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.who.int\/today."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00428-023-03552-3","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer\u2014Update 2023","volume":"482","author":"Cibula","year":"2023","journal-title":"Virchows Archiv"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.6004\/jnccn.2023.0062","article-title":"NCCN Guidelines\u00ae insights: Cervical cancer, version 1.2024: Featured updates to the NCCN guidelines","volume":"21","author":"Yashar","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_5","first-page":"48","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"Tanderup","year":"2018","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2016.05.014","article-title":"Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer","volume":"120","author":"Tanderup","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.clon.2023.05.013","article-title":"Challenges in the sustainability of brachytherapy service in contemporary radiotherapy","volume":"35","author":"Swain","year":"2023","journal-title":"Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.radonc.2010.09.009","article-title":"Patterns of care for brachytherapy in Europe: Updated results","volume":"97","author":"Guedea","year":"2010","journal-title":"Radiother. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.radonc.2006.11.011","article-title":"Overview of brachytherapy resources in Europe: A survey of patterns of care study for brachytherapy in Europe","volume":"82","author":"Guedea","year":"2007","journal-title":"Radiother. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.rpor.2015.05.006","article-title":"Pattern of radiotherapy care in Bulgaria","volume":"20","author":"Hadjieva","year":"2015","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_11","unstructured":"(2025, May 13). Available online: https:\/\/dirac.iaea.org\/Query\/Countries."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4329\/wjr.v9.i4.148","article-title":"New era of electronic brachytherapy","volume":"9","author":"Ramachandran","year":"2017","journal-title":"World J. Radiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/acm2.12657","article-title":"Treatment of cervical cancer with electronic brachytherapy","volume":"20","year":"2019","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.brachy.2022.01.006","article-title":"Feasibility of electronic brachytherapy in cervix cancer\u2013A dosimetric comparison of different brachytherapy techniques","volume":"21","author":"Ruggeri","year":"2022","journal-title":"Brachytherapy"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijrobp.2008.10.033","article-title":"Dose\u2013volume histogram parameters and local tumor control in magnetic resonance image\u2013guided cervical cancer brachytherapy","volume":"75","author":"Dimopoulos","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijrobp.2021.04.022","article-title":"Nomogram predicting overall survival in patients with locally advanced cervical cancer treated with radiochemotherapy including image-guided brachytherapy: A retro-EMBRACE study","volume":"111","author":"Sturdza","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(24)01808-7","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): Overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"404","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s10147-024-02490-7","article-title":"MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: A subgroup analysis of a phase II prospective trial","volume":"29","author":"Kang","year":"2024","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"110263","DOI":"10.1016\/j.radonc.2024.110263","article-title":"MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy","volume":"195","author":"Skipar","year":"2024","journal-title":"Radiother. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.radonc.2014.11.045","article-title":"Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy","volume":"114","author":"Mazeron","year":"2015","journal-title":"Radiother. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2021.08.020","article-title":"Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis","volume":"163","author":"Peters","year":"2021","journal-title":"Radiother. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.radonc.2013.04.015","article-title":"The size of the metastatic lymph node is an independent prognostic factor for the patients with cervical cancer treated by definitive radiotherapy","volume":"108","author":"Song","year":"2013","journal-title":"Radiother. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ijrobp.2014.08.013","article-title":"Extended field intensity modulated radiation therapy with concomitant boost for lymph node\u2013positive cervical cancer: Analysis of regional control and recurrence patterns in the positron emission tomography\/computed tomography era","volume":"90","author":"Vargo","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3109\/0284186X.2015.1061693","article-title":"Impact of radiation dose and standardized uptake value of (18) FDG PET on nodal control in locally advanced cervical cancer","volume":"54","author":"Ramlov","year":"2015","journal-title":"Acta Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/CCO.0000000000000471","article-title":"The management of locally advanced cervical cancer","volume":"30","author":"Ch","year":"2018","journal-title":"Curr. Opin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2014.02.004","article-title":"Distant metastasis in patients with cervical cancer after primary radiotherapy with or without chemotherapy and image guided adaptive brachytherapy","volume":"133","author":"Schmid","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e35757","DOI":"10.1002\/cncr.35757","article-title":"Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer","volume":"131","author":"Duska","year":"2025","journal-title":"Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semradonc.2020.05.008","article-title":"Evidence-based dose planning aims and dose prescription in image-guided brachytherapy combined with radiochemotherapy in locally advanced cervical cancer","volume":"Volume 30","author":"Tanderup","year":"2020","journal-title":"Seminars in Radiation Oncology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.radonc.2021.01.019","article-title":"Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.radonc.2020.10.003","article-title":"Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1016\/j.clon.2021.02.011","article-title":"Ultrasound-guided brachytherapy for cervix cancer","volume":"33","author":"Khaw","year":"2021","journal-title":"Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Manea, E., Chitoran, E., Rotaru, V., Ionescu, S., Luca, D., Cirimbei, C., Alecu, M., Capsa, C., Gafton, B., and Prutianu, I. (2024). Integration of Ultrasound in Image-Guided Adaptive Brachytherapy in Cancer of the Uterine Cervix. Bioengineering, 11.","DOI":"10.3390\/bioengineering11050506"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2016.06.006","article-title":"Dose\u2013volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study","volume":"120","author":"Mazeron","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijrobp.2020.10.006","article-title":"Dose-volume effects and risk factors for late diarrhea in cervix cancer patients after radiochemotherapy with image guided adaptive brachytherapy in the EMBRACE I study","volume":"109","author":"Jensen","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ijrobp.2023.01.002","article-title":"Overall severe morbidity after chemo-radiation therapy and magnetic resonance imaging-guided adaptive brachytherapy in locally advanced cervical cancer: Results from the EMBRACE-I study","volume":"116","author":"Vittrup","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/14\/2286\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:07:12Z","timestamp":1760033232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/14\/2286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":35,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["cancers17142286"],"URL":"https:\/\/doi.org\/10.3390\/cancers17142286","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]}}}